Figure 5.
Schematic overview of possible novel TME–directed trial designs. The 4R objectives of TME trials are ordered according to the classical phases of CLL therapy design, and novel drugs are allocated to these principles below. Future trials can be designed by rationally choosing the respective drug combinations.